Literature DB >> 6057492

Quantitative determination of the neutral glycosyl ceramides in human blood.

D E Vance, C C Sweeley.   

Abstract

A method is described for the qualitative and quantitative estimation of four neutral glycosyl ceramides from human plasma and erythrocytes. Total lipids extracted from 50 ml of plasma or packed erythrocytes were separated by silicic acid chromatography into neutral lipids, a fraction of mixed glycolipids that was eluted with acetone-methanol 9:1, and phospholipids. After mild alkali-catalyzed methanolysis to remove contaminants from the crude fraction of glycolipids, individual glycosyl ceramides were isolated by preparative thin-layer chromatography. The oligosaccharide portions of these lipids were characterized by cleavage with methanolic hydrogen chloride and gas chromatography of the O-trimethylsilyl methyl glycosides. It was possible to study the composition of the carbohydrate and sphingolipid base fractions in the same gas chromatographic analysis. With mannitol as an internal standard for gas chromatographic estimation of glucose, concentrations of each of the glycosyl ceramides were determined with a precision of about 10%. Recoveries of the lipids from plasma varied with the complexity of the oligosaccharide moiety and ranged from 94% with glucosyl ceramide to 71% with globoside. Concentrations of the four glycosyl ceramides in plasma and in erythrocytes were determined for samples from young, healthy males. Amounts of glycolipid as low as 0.1 micromole can be determined conveniently by this procedure.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6057492

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  90 in total

1.  The occurrence of a phosphorylated glycosphingolipid in Aspergillus niger.

Authors:  P J Brennan; J Roe
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

2.  Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

Authors:  R J Desnick; K J Dean; G Grabowski; D F Bishop; C C Sweeley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

3.  Extensive homology between the subunits of the phytohemagglutinin mitogenic proteins derived from Phaseolus vulgaris.

Authors:  J B Miller; R Hsu; R Heinrikson; S Yachnin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

4.  Metabolism of peripheral nerve monogalactosylceramides.

Authors:  J K Yao
Journal:  Lipids       Date:  1989-10       Impact factor: 1.880

5.  Metabolic fate of sphingomyelin of high-density lipoprotein in rat plasma.

Authors:  M Bentejac; M Bugaut; M C Delachambre; J Lecerf
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

6.  Glycoproteins and glycolipids of rat small intestinal microvillus and basolateral membranes.

Authors:  A Morita; B Siddiqui; R H Erickson; Y S Kim
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

7.  Studies on human platelet gangliosides.

Authors:  A J Marcus; H L Ullman; L B Safier
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  Composition of lipids of bovine optic nerve.

Authors:  S K Das; M E Steen; M S McCullough; D K Bhattacharyya
Journal:  Lipids       Date:  1978-10       Impact factor: 1.880

9.  Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).

Authors:  M Rasmussen; A B Moser; J Borel; S Khangoora; H W Moser
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

10.  Neuronal lipidosis and neuroaxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome.

Authors:  J M Powers; R C Tummons; A B Moser; H W Moser; D S Huff; R I Kelley
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.